Our Blog
Insights on regulatory affairs, quality, pharmacovigilance and RNA technologies from the Molgenium team.
Advanced Therapies (ATMPs & mRNA)
How to Define Clinically Relevant Specifications for mRNA Products
By Dr. Mohamad Toutounji
Mar 21, 2026